West Pharma (WST) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $394.03 +0.14%
EPS Growth %: +12.2%
Financial Fact:
Gross profit: 121.1M
Today's EPS Names:
ORPB, PBCO, SICP, More
EPS Growth %: +12.2%
Financial Fact:
Gross profit: 121.1M
Today's EPS Names:
ORPB, PBCO, SICP, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q2 EPS of $0.52, $0.05 better than the analyst estimate of $0.47. Revenue for the quarter came in at $368.9 million versus the consensus estimate of $368.6 million.
West Pharmaceutical Services, Inc. reaffirmed FY2014 guidance.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Consumer Portfolio Services (CPSS) Reports Q3 EPS of $0.30
- Knowles (KN) Tops Q3 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
